ID   APOA2_HUMAN             Reviewed;         100 AA.
AC   P02652; B2R524;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   10-MAY-2017, entry version 204.
DE   RecName: Full=Apolipoprotein A-II;
DE            Short=Apo-AII;
DE            Short=ApoA-II;
DE   AltName: Full=Apolipoprotein A2;
DE   Contains:
DE     RecName: Full=Proapolipoprotein A-II;
DE              Short=ProapoA-II;
DE   Contains:
DE     RecName: Full=Truncated apolipoprotein A-II;
DE     AltName: Full=Apolipoprotein A-II(1-76);
DE   Flags: Precursor;
GN   Name=APOA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6428397; DOI=10.1016/S0006-291X(84)80168-0;
RA   Knott T.J., Priestley L.M., Urdea M., Scott J.;
RT   "Isolation and characterisation of a cDNA encoding the precursor for
RT   human apolipoprotein AII.";
RL   Biochem. Biophys. Res. Commun. 120:734-740(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6089788; DOI=10.1016/0006-291X(84)90371-1;
RA   Moore M.N., Kao F.-T., Tsao Y.-K., Chan L.;
RT   "Human apolipoprotein A-II: nucleotide sequence of a cloned cDNA, and
RT   localization of its structural gene on human chromosome 1.";
RL   Biochem. Biophys. Res. Commun. 123:1-7(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6328445; DOI=10.1093/nar/12.9.3917;
RA   Sharpe C.R., Sidoli A., Shelley C.S., Lucero M.A., Shoulders C.C.,
RA   Baralle F.E.;
RT   "Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA
RT   abundance.";
RL   Nucleic Acids Res. 12:3917-3932(1984).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2989800; DOI=10.1093/nar/13.12.4597;
RA   Lackner K.J., Law S.W., Brewer H.B. Jr.;
RT   "The human apolipoprotein A-II gene: complete nucleic acid sequence
RT   and genomic organization.";
RL   Nucleic Acids Res. 13:4597-4608(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2995928; DOI=10.1093/nar/13.17.6387;
RA   Knott T.J., Wallis S.C., Robertson M.E., Priestley L.M., Urdea M.,
RA   Rall L.B., Scott J.;
RT   "The human apolipoprotein AII gene: structural organization and sites
RT   of expression.";
RL   Nucleic Acids Res. 13:6387-6398(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3088392; DOI=10.1016/0076-6879(86)28103-3;
RA   Chan L., Moore M.N., Tsao Y.-K.;
RT   "Molecular cloning and sequence analysis of human apolipoprotein A-II
RT   cDNA.";
RL   Methods Enzymol. 128:745-752(1986).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12136239; DOI=10.1007/s00439-002-0763-x;
RA   Fullerton S.M., Clark A.G., Weiss K.M., Taylor S.L., Stengard J.H.,
RA   Salomaa V., Boerwinkle E., Nickerson D.A.;
RT   "Sequence polymorphism at the human apolipoprotein AII gene (APOA2):
RT   unexpected deficit of variation in an African-American sample.";
RL   Hum. Genet. 111:75-87(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 24-100, AND PYROGLUTAMATE FORMATION AT GLN-24.
RX   PubMed=4344225;
RA   Lux S.E., John K.M., Ronan R., Brewer H.B. Jr.;
RT   "Isolation and characterization of the tryptic and cyanogen bromide
RT   peptides of apoLp-Gln-II (apoA-II), plasma high density
RT   apolipoprotein.";
RL   J. Biol. Chem. 247:7519-7527(1972).
RN   [13]
RP   PROTEIN SEQUENCE OF 25-37, MASS SPECTROMETRY, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND PYROGLUTAMATE FORMATION AT GLN-24.
RX   PubMed=24116940; DOI=10.1089/adt.2013.511;
RA   Su M., Qi Y., Wang M., Chang W., Peng S., Xu T., Wang D.;
RT   "Expression and purification of recombinant human apolipoprotein A-II
RT   in Pichia pastoris.";
RL   Assay Drug Dev. Technol. 11:501-507(2013).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE OF 1-29.
RX   PubMed=6407957;
RA   Stoffel W., Krueger E., Deutzmann R.;
RT   "Cell-free translation of human liver apolipoprotein AI and AII mRNA.
RT   Processing of primary translation products.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:227-237(1983).
RN   [15]
RP   POLYMORPHISM.
RX   PubMed=2107739;
RA   Deeb S.S., Takata K., Peng R.L., Kajiyama G., Albers J.J.;
RT   "A splice-junction mutation responsible for familial apolipoprotein A-
RT   II deficiency.";
RL   Am. J. Hum. Genet. 46:822-827(1990).
RN   [16]
RP   INTERCHAIN DISULFIDE BOND WITH APOD.
RC   TISSUE=Plasma;
RX   PubMed=7918467; DOI=10.1021/bi00207a011;
RA   Yang C.-Y., Gu Z.-W., Blanco-Vaca F., Gaskell S.J., Yang M.,
RA   Massey J.B., Gotto A.M. Jr., Pownall H.J.;
RT   "Structure of human apolipoprotein D: locations of the intermolecular
RT   and intramolecular disulfide links.";
RL   Biochemistry 33:12451-12455(1994).
RN   [17]
RP   INTERACTION WITH APOA1BP.
RX   PubMed=11991719; DOI=10.1006/geno.2002.6761;
RA   Ritter M., Buechler C., Boettcher A., Barlage S., Schmitz-Madry A.,
RA   Orso E., Bared S.M., Schmiedeknecht G., Baehr C.H., Fricker G.,
RA   Schmitz G.;
RT   "Cloning and characterization of a novel apolipoprotein A-I-binding
RT   protein, AI-BP, secreted by cells of the kidney proximal tubules in
RT   response to HDL or ApoA-I.";
RL   Genomics 79:693-702(2002).
RN   [18]
RP   MASS SPECTROMETRY, AND OXIDATION AT MET-49.
RX   PubMed=12576517; DOI=10.1194/jlr.M200256-JLR200;
RA   Pankhurst G., Wang X.L., Wilcken D.E., Baernthaler G., Panzenboeck U.,
RA   Raftery M., Stocker R.;
RT   "Characterization of specifically oxidized apolipoproteins in mildly
RT   oxidized high density lipoprotein.";
RL   J. Lipid Res. 44:349-355(2003).
RN   [19]
RP   MASS SPECTROMETRY, AND SUBUNIT.
RX   PubMed=12562854; DOI=10.1194/jlr.D200034-JLR200;
RA   Niederkofler E.E., Tubbs K.A., Kiernan U.A., Nedelkov D., Nelson R.W.;
RT   "Novel mass spectrometric immunoassays for the rapid structural
RT   characterization of plasma apolipoproteins.";
RL   J. Lipid Res. 44:630-639(2003).
RN   [20]
RP   INTERACTION WITH NDRG1.
RX   PubMed=15922294; DOI=10.1016/j.bbrc.2005.05.050;
RA   Hunter M., Angelicheva D., Tournev I., Ingley E., Chan D.C.,
RA   Watts G.F., Kremensky I., Kalaydjieva L.;
RT   "NDRG1 interacts with APO A-I and A-II and is a functional candidate
RT   for the HDL-C QTL on 8q24.";
RL   Biochem. Biophys. Res. Commun. 332:982-992(2005).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Serum;
RX   PubMed=19824718; DOI=10.1021/pr900603n;
RA   Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,
RA   Liotta L.A., Petricoin E.F. III;
RT   "An initial characterization of the serum phosphoproteome.";
RL   J. Proteome Res. 8:5523-5531(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   PHOSPHORYLATION AT SER-54 AND SER-68.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 24-100, SUBUNIT, AND
RP   DISULFIDE BOND.
RX   PubMed=12269810; DOI=10.1021/bi026069w;
RA   Kumar M.S., Carson M., Hussain M.M., Murthy H.M.;
RT   "Structures of apolipoprotein A-II and a lipid-surrogate complex
RT   provide insights into apolipoprotein-lipid interactions.";
RL   Biochemistry 41:11681-11691(2002).
CC   -!- FUNCTION: May stabilize HDL (high density lipoprotein) structure
CC       by its association with lipids, and affect the HDL metabolism.
CC   -!- SUBUNIT: Monomer. Homodimer; disulfide-linked. Also forms a
CC       disulfide-linked heterodimer with APOD. Interacts with HCV core
CC       protein. Interacts with APOA1BP and NDRG1.
CC       {ECO:0000269|PubMed:11991719, ECO:0000269|PubMed:12269810,
CC       ECO:0000269|PubMed:12562854, ECO:0000269|PubMed:15922294,
CC       ECO:0000269|PubMed:24116940}.
CC   -!- INTERACTION:
CC       Q8NEC5:CATSPER1; NbExp=5; IntAct=EBI-1171525, EBI-744545;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:24116940}.
CC   -!- TISSUE SPECIFICITY: Plasma; synthesized in the liver and
CC       intestine.
CC   -!- PTM: Phosphorylation sites are present in the extracellular
CC       medium. {ECO:0000269|PubMed:26091039}.
CC   -!- PTM: Apolipoprotein A-II is O-glycosylated.
CC       {ECO:0000269|PubMed:23234360}.
CC   -!- MASS SPECTROMETRY: Mass=17252; Method=Electrospray; Range=24-100;
CC       Note=Homodimer, without methionine sulfoxide.;
CC       Evidence={ECO:0000269|PubMed:12576517};
CC   -!- MASS SPECTROMETRY: Mass=17269; Method=Electrospray; Range=24-100;
CC       Note=Homodimer, with 1 methionine sulfoxide, oxidation at Met-49.;
CC       Evidence={ECO:0000269|PubMed:12576517};
CC   -!- MASS SPECTROMETRY: Mass=8701.2; Method=MALDI; Range=24-100;
CC       Note=Monomer.; Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=8823.4; Method=MALDI; Range=24-100;
CC       Note=Cysteinylated ApoA-II monomer.;
CC       Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=17421.3; Method=MALDI; Range=24-100;
CC       Note=Homodimer.; Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=17293.4; Method=MALDI; Range=24-100;
CC       Note=Heterodimer with truncated apolipoprotein A-II.;
CC       Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=8578.3; Method=MALDI; Range=24-99;
CC       Note=Monomer.; Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=17166.2; Method=MALDI; Range=24-99;
CC       Note=Homodimer.; Evidence={ECO:0000269|PubMed:12562854};
CC   -!- MASS SPECTROMETRY: Mass=17380; Method=MALDI; Range=25-100;
CC       Note=Homodimer.; Evidence={ECO:0000269|PubMed:24116940};
CC   -!- POLYMORPHISM: A homozygous transition at position 1 of intron 3 of
CC       APOA2 results in deficiency of apolipoprotein A-II, without
CC       significant influence either on lipid and lipoprotein profiles or
CC       on the occurrence of coronary artery disease [MIM:107670].
CC       {ECO:0000269|PubMed:2107739}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A2 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=APOA2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04898; CAA28583.1; -; Genomic_DNA.
DR   EMBL; X00955; CAA25467.1; -; mRNA.
DR   EMBL; X02905; CAA26665.1; -; Genomic_DNA.
DR   EMBL; X02619; CAA26474.1; -; Genomic_DNA.
DR   EMBL; M29882; AAA51701.1; -; mRNA.
DR   EMBL; AY100524; AAM49807.1; -; Genomic_DNA.
DR   EMBL; AK312034; BAG34971.1; -; mRNA.
DR   EMBL; BT006786; AAP35432.1; -; mRNA.
DR   EMBL; AL590714; CAH72151.1; -; Genomic_DNA.
DR   EMBL; BC005282; AAH05282.1; -; mRNA.
DR   CCDS; CCDS1226.1; -.
DR   PIR; A93586; LPHUA2.
DR   RefSeq; NP_001634.1; NM_001643.1.
DR   UniGene; Hs.237658; -.
DR   PDB; 1L6L; X-ray; 2.30 A; 1/2/3/4/5/6/7/8/A/B/C/D/E/F/G/H/I/J/K/L/M/N/P/Q/S/T/U/V/W/X/Y/Z=24-100.
DR   PDB; 2OU1; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=24-100.
DR   PDBsum; 1L6L; -.
DR   PDBsum; 2OU1; -.
DR   ProteinModelPortal; P02652; -.
DR   SMR; P02652; -.
DR   BioGrid; 106833; 14.
DR   IntAct; P02652; 9.
DR   MINT; MINT-106326; -.
DR   STRING; 9606.ENSP00000356969; -.
DR   iPTMnet; P02652; -.
DR   PhosphoSitePlus; P02652; -.
DR   BioMuta; APOA2; -.
DR   DMDM; 114000; -.
DR   SWISS-2DPAGE; P02652; -.
DR   MaxQB; P02652; -.
DR   PaxDb; P02652; -.
DR   PeptideAtlas; P02652; -.
DR   PRIDE; P02652; -.
DR   TopDownProteomics; P02652; -.
DR   DNASU; 336; -.
DR   Ensembl; ENST00000367990; ENSP00000356969; ENSG00000158874.
DR   GeneID; 336; -.
DR   KEGG; hsa:336; -.
DR   UCSC; uc001fzc.2; human.
DR   CTD; 336; -.
DR   DisGeNET; 336; -.
DR   GeneCards; APOA2; -.
DR   HGNC; HGNC:601; APOA2.
DR   HPA; CAB025885; -.
DR   MalaCards; APOA2; -.
DR   MIM; 107670; gene+phenotype.
DR   neXtProt; NX_P02652; -.
DR   OpenTargets; ENSG00000158874; -.
DR   Orphanet; 238269; Familial renal amyloidosis due to Apolipoprotein AII variant.
DR   PharmGKB; PA24886; -.
DR   eggNOG; ENOG410KCI2; Eukaryota.
DR   eggNOG; ENOG4110NY0; LUCA.
DR   GeneTree; ENSGT00390000003306; -.
DR   HOGENOM; HOG000033999; -.
DR   HOVERGEN; HBG050544; -.
DR   InParanoid; P02652; -.
DR   KO; K08758; -.
DR   PhylomeDB; P02652; -.
DR   TreeFam; TF338165; -.
DR   Reactome; R-HSA-174800; Chylomicron-mediated lipid transport.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   ChiTaRS; APOA2; human.
DR   EvolutionaryTrace; P02652; -.
DR   GeneWiki; APOA2; -.
DR   GenomeRNAi; 336; -.
DR   PMAP-CutDB; P02652; -.
DR   PRO; PR:P02652; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000158874; -.
DR   CleanEx; HS_APOA2; -.
DR   ExpressionAtlas; P02652; baseline and differential.
DR   Genevisible; P02652; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0042627; C:chylomicron; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; TAS:Reactome.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0034366; C:spherical high-density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0034190; F:apolipoprotein receptor binding; IPI:BHF-UCL.
DR   GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
DR   GO; GO:0017127; F:cholesterol transporter activity; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:CAFA.
DR   GO; GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl.
DR   GO; GO:0070653; F:high-density lipoprotein particle receptor binding; IPI:BHF-UCL.
DR   GO; GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0008289; F:lipid binding; IDA:BHF-UCL.
DR   GO; GO:0005319; F:lipid transporter activity; IDA:BHF-UCL.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IDA:BHF-UCL.
DR   GO; GO:0005543; F:phospholipid binding; IDA:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0002526; P:acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0033344; P:cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; IDA:BHF-UCL.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; IDA:BHF-UCL.
DR   GO; GO:0034384; P:high-density lipoprotein particle clearance; IDA:BHF-UCL.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; TAS:Reactome.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0060621; P:negative regulation of cholesterol import; IDA:BHF-UCL.
DR   GO; GO:0032375; P:negative regulation of cholesterol transport; IMP:BHF-UCL.
DR   GO; GO:0060695; P:negative regulation of cholesterol transporter activity; IDA:BHF-UCL.
DR   GO; GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:BHF-UCL.
DR   GO; GO:0060192; P:negative regulation of lipase activity; IDA:BHF-UCL.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0018206; P:peptidyl-methionine modification; IDA:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0009395; P:phospholipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0033700; P:phospholipid efflux; IDA:BHF-UCL.
DR   GO; GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL.
DR   GO; GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0018158; P:protein oxidation; IDA:UniProtKB.
DR   GO; GO:0030300; P:regulation of intestinal cholesterol absorption; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IDA:BHF-UCL.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0043691; P:reverse cholesterol transport; IDA:BHF-UCL.
DR   GO; GO:0006641; P:triglyceride metabolic process; TAS:BHF-UCL.
DR   GO; GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR006801; ApoA-II.
DR   PANTHER; PTHR11027; PTHR11027; 1.
DR   ProDom; PD010397; ApoA-II; 1.
DR   SUPFAM; SSF82936; SSF82936; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; HDL;
KW   Host-virus interaction; Lipid transport; Oxidation; Phosphoprotein;
KW   Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal;
KW   Transport.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:6328445}.
FT   CHAIN        19    100       Proapolipoprotein A-II.
FT                                /FTId=PRO_0000425351.
FT   CHAIN        24    100       Apolipoprotein A-II.
FT                                {ECO:0000269|PubMed:4344225}.
FT                                /FTId=PRO_0000002003.
FT   CHAIN        24     99       Truncated apolipoprotein A-II.
FT                                {ECO:0000305|PubMed:12562854}.
FT                                /FTId=PRO_0000002004.
FT   REGION       32     43       O-glycosylated at one site.
FT   MOD_RES      24     24       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:24116940,
FT                                ECO:0000269|PubMed:4344225}.
FT   MOD_RES      49     49       Methionine sulfoxide.
FT                                {ECO:0000269|PubMed:12576517}.
FT   MOD_RES      54     54       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES      68     68       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:19824718,
FT                                ECO:0000269|PubMed:26091039}.
FT   DISULFID     29     29       Interchain (with C-136 in APOD); in
FT                                heterodimeric form.
FT                                {ECO:0000269|PubMed:12269810}.
FT   CONFLICT     96     96       Q -> H (in Ref. 1; CAA28583).
FT                                {ECO:0000305}.
FT   HELIX        31     56       {ECO:0000244|PDB:2OU1}.
FT   STRAND       58     60       {ECO:0000244|PDB:2OU1}.
FT   HELIX        63     69       {ECO:0000244|PDB:2OU1}.
FT   TURN         70     72       {ECO:0000244|PDB:2OU1}.
FT   HELIX        74     77       {ECO:0000244|PDB:2OU1}.
FT   HELIX        79     82       {ECO:0000244|PDB:2OU1}.
FT   HELIX        88     95       {ECO:0000244|PDB:2OU1}.
FT   TURN         96     98       {ECO:0000244|PDB:2OU1}.
SQ   SEQUENCE   100 AA;  11175 MW;  1247868A25EC3AF2 CRC64;
     MKLLAATVLL LTICSLEGAL VRRQAKEPCV ESLVSQYFQT VTDYGKDLME KVKSPELQAE
     AKSYFEKSKE QLTPLIKKAG TELVNFLSYF VELGTQPATQ
//
